PTEN Hamartoma Tumor Syndrome
9
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Familial Investigations of Childhood Cancer Predisposition
PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry
Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations
Sirolimus for Cowden Syndrome With Colon Polyposis
RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients
Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations
Response of Immune System to Flu Vaccination in PHTS